1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        North America Allergy Immunotherapies Market – By Treatment

1.3.2        North America Allergy Immunotherapies Market – By Allergy Type

1.3.3        North America Allergy Immunotherapies Market – By Distribution Channel

1.3.4        North America Allergy Immunotherapies Market – By Geography

2.          North America Allergy Immunotherapies Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          North America Allergy Immunotherapies Market – Market Landscape

4.1        Overview

4.2        North America - PEST Analysis

4.3        Expert Opinion

5.          North America Allergy immunotherapies Market – Key Market Dynamics

5.1        Key Market Drivers

5.1.1        Growing Prevalence of Allergic Disorders

5.1.2        Technological Advancements in Sublingual Dosage Formulations

5.2        Key Market Restraint

5.2.1        Drawbacks Associated with the Use of Allergy Immunotherapy

5.2.2        Regulatory Variations Across Regions

5.3        Key Market Opportunities

5.3.1        Presence of Strong Product Pipeline

5.4        Future Trends

5.4.1        Increasing FDA Approvals for Drugs

5.5        Impact Analysis

6.          Allergy Immunotherapies Market – North America Analysis

6.1.1        North America: Allergy immunotherapies market - Revenue and Forecast to 2027 (US$ Million)

7.          North America Allergy Immunotherapies Market Analysis– by Treatment

7.1        Overview

7.2        North America Allergy Immunotherapies Market Share, By Treatment, 2019 & 2027 (%)

7.3        Subcutaneous Immunotherapy (SCIT)

7.3.1        Overview

7.3.2        North America Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)

7.4        Sublingual Immunotherapy (SLIT)

7.4.1        Overview

7.4.2        North America Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)

8.          North America Allergy Immunotherapies Market Analysis– by Allergy Type

8.1        Overview

8.2        North America Allergy Immunotherapies Market Share, By Allergy Type, 2019 & 2027 (%)

8.3        Allergic Rhinitis

8.3.1        Overview

8.3.2        Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)

8.4        Asthma

8.4.1        Overview

8.4.2        Asthma Market Revenue and Forecasts to 2027 (US$ Million)

8.5        Food Allergy

8.5.1        Overview

8.5.2        Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)

8.6        Venom Allergy

8.6.1        Overview

8.6.2        Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)

8.7        Other Allergies

8.7.1        Overview

8.7.2        Others Market Revenue and Forecasts to 2027 (US$ Million)

9.          North America Allergy Immunotherapies Market Analysis– by Distribution Channel

9.1        Overview

9.2        North America Allergy Immunotherapies Market Share, By Distribution Channel, 2019 & 2027 (%)

9.3        Hospital Pharmacy

9.3.1        Overview

9.3.2        North America Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)

9.4        Retail Pharmacy

9.4.1        Overview

9.4.2        North America Retail PharmacyMarket Revenue and Forecasts to 2027 (US$ Million)

9.5        Online Pharmacy

9.5.1        Overview

9.5.2        North America Online PharmacyMarket Revenue and Forecasts to 2027 (US$ Million)

10.       Allergy Immunotherapies – Geographic Analysis

10.1.1     Overview

10.1.2     orth America: Allergy immunotherapies market - Revenue and Forecast to 2027 (US$ Million)

10.1.3     North America: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

10.1.4     North America Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

10.1.5     North America Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.6     North America: Allergy immunotherapies market, by Country, 2019 & 2027 (%)

10.1.7     US: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1       US: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2       US Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

10.1.7.3       US Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

10.1.7.4       US Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.8     Canada: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1       Canada: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2       Canada Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)

10.1.8.3       Canada Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

10.1.8.4       Canada Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.9     Mexico: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1       Mexico: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2       Mexico Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)

10.1.9.3       Mexico Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

10.1.9.4       Mexico Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.       Impact of COVID-19 Pandemic on North America Allergy Immunotherapies Market

12.       Company Profiles

12.1     ALK-Abelló A/S

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2     AIMMUNE THERAPEUTICS, INC.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3     Johnson and Johnson Services, Inc.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

13.       Appendix

13.1     Glossary of Terms

LIST OF TABLES

Table 1.            North America Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 2.            North America Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

Table 3.            North America Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 4.            US Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 5.            US Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

Table 6.            US Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 7.            Canada Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 8.            Canada Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

Table 9.            Canada Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 10.         Mexico Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 11.         Mexico Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

Table 12.         Mexico Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13.         Glossary of Terms, Allergy Immunotherapies Market

LIST OF FIGURES

Figure 1.          North America Allergy Immunotherapies Market Segmentation

Figure 2.          North America Allergy Immunotherapies Market Overview

Figure 3.          Subcutaneous Immunotherapy (SCIT) Segment Held Largest Share of Allergy immunotherapies market

Figure 4.          United States Is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.          North America Allergy Immunotherapies Market- Leading Country Markets (US$ Million)

Figure 6.          North America PEST Analysis

Figure 7.          Allergy immunotherapies Market Impact Analysis of Driver and Restraints

Figure 8.          North America Allergy immunotherapies market Revenue and Forecast to 2027 (USD Million)

Figure 9.          North America Allergy Immunotherapies Market Share, by Treatment, 2019 & 2027 (%)

Figure 10.        North America Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)

Figure 11.        North America Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)

Figure 12.        North America Allergy Immunotherapies Market Share, by Allergy Type, 2019 & 2027 (%)

Figure 13.        Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)

Figure 14.        Asthma Market Revenue and Forecasts to 2027 (US$ Million)

Figure 15.        Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)

Figure 16.        Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)

Figure 17.        Others Market Revenue and Forecasts to 2027 (US$ Million)

Figure 18.        North America Allergy Immunotherapies Market Share, by Distribution Channel, 2019 & 2027 (%)

Figure 19.        North America Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)

Figure 20.        North America Retail PharmacyMarket Revenue and Forecasts to 2027 (US$ Million)

Figure 21.        North America Online Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)

Figure 22.        North America: Allergy Immunotherapies Market, by Key Country – Revenue (2019) (USD Million)

Figure 23.        North America Allergy immunotherapies market Revenue and Forecast to 2027 (USD Million)

Figure 24.        North America: Allergy immunotherapies market, by Country, 2019 & 2027 (%)

Figure 25.        US: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        Canada: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        Mexico: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        Impact of COVID-19 Pandemic on allergy immunotherapies market in North American Countries